Editorials

Smoldering multiple myeloma: special considerations surrounding treatment on versus off clinical trials

Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX;
Myeloma Service, Memorial Sloan-Kettering Cancer Center, New York, NY;
Multiple Myeloma Section, Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, USA.
Multiple Myeloma Section, Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, USA.
Multiple Myeloma Section, Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, USA.
Multiple Myeloma Section, Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, USA.
Myeloma Service, Memorial Sloan-Kettering Cancer Center, New York, NY;
Vol. 99 No. 12 (2014): December, 2014 https://doi.org/10.3324/haematol.2014.107516